iSpecimen Inc. (ISPC) vs MBody AI Ltd. (MBAI)

A side-by-side comparison of iSpecimen Inc. and MBody AI Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
iSpecimen Inc. logo
ISPC
iSpecimen Inc.
$3M
$1.07HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MBody AI Ltd. logo
MBAI
MBody AI Ltd.
$3M
$3.24HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ISPC vs MBAI

growth of $100 · dividends reinvested · last 1y
ISPC -96.5% (-96.5%/yr)MBAI -67.4% (-67.4%/yr)MBAI compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002026$4$33
ISPC MBAI

ISPC vs MBAI: by the numbers

  • •MBAI is the larger company ($3M vs $3M market cap).
  • •Both run net losses; MBAI's is the smaller (0.00% vs -2449.04% net margin).

Metrics side by side

Valuation

MetricISPCMBAI
P/S ratio5.78N/A
P/B ratio1.550.95

Profitability

MetricISPCMBAI
Gross margin1.25%0.00%
Operating margin-465.42%0.00%
Net margin-2449.04%0.00%
ROE-657.69%120.45%
ROIC-476.39%-69.04%

Growth (annualized)

MetricISPCMBAI
Revenue CAGR (5Y)-46.70%N/A
Total return CAGR (5Y)-81.14%N/A

Go deeper

Full ISPC analysisFull MBAI analysisInteractive comparison tool

Dig into the metrics

iSpecimen ROEMBody AI ROEiSpecimen operating marginMBody AI operating marginiSpecimen revenue growthMBody AI revenue growthiSpecimen free cash flowMBody AI free cash flow

iSpecimen & MBody AI appear in these rankings

Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.